Search

everythinglearnresearchcommunity

for

Search:↓

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Lower SHBG levels may increase the risk of PCOS.

Androgens are important for normal ovarian function and estrogen production, but may not be the main cause of follicle death.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Ginsenoside F2 may help prevent hair loss and promote hair growth better than finasteride.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Polygonum multiflorum extract helps hair grow longer and fights the effects of hormones that cause hair loss.

Hsc70 protein may influence hair growth by responding to androgens.

Testosterone therapy can help women with androgen deficiency by improving energy, sex drive, and bone health with few side effects.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

Androgens reduce BMP2, which weakens the ability of certain cells to help hair stem cells become different types of cells.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

A protein called ectodysplasin-A2 increases a hair growth inhibitor in balding cells, which could be a target for hair loss treatment.

Melatonin receptors, found in many body parts, can help treat various diseases like depression and diabetes due to their effects on inflammation, tumor progression, sleep disorders, and body mass regulation.

Excess maternal androgens can cause heart problems in offspring.

The mouse models are effective for testing new hair loss treatments.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

Women with PCOS had higher SRAGE levels, possibly linked to BMI, not PCOS.

Human scalp hair follicles have PGE2 and its receptors, which might affect hair growth.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Women with myotonic dystrophy might get diseases related to male hormones because their body tissues are extra sensitive to these hormones.